Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report.

Calapre, Leslie; Warburton, Lydia; Millward, Michael; Gray, Elin S

Calapre, Leslie; Warburton, Lydia; Millward, Michael; Gray, Elin S.

Affiliation

Calapre L; School of Medical Science, Edith Cowan University, Joondalup, WA, Australia.
Warburton L; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. Lydia.warburton@health.wa.gov.au.
Millward M; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Gray ES; School of Medicine and Pharmacology, The University of Western Australia, Crawley, Western Australia, Australia.

BMC Cancer ; 19(1): 1109, 2019 Nov 14.

Article in En | MEDLINE | ID: mdl-31727009

Subject(s)

Circulating Tumor DNA/blood; Colorectal Neoplasms/blood; Melanoma/blood; Neoplasms, Second Primary/drug therapy; Aged; Biomarkers, Tumor/blood; CTLA-4 Antigen/antagonists & inhibitors; CTLA-4 Antigen/genetics; Colorectal Neoplasms/pathology; Disease Progression; Humans; Male; Melanoma/pathology; Melanoma/secondary; Mutation; Neoplasms, Second Primary/blood; Neoplasms, Second Primary/genetics; Neoplasms, Second Primary/pathology; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Programmed Cell Death 1 Receptor/genetics; Proto-Oncogene Proteins B-raf/blood; Proto-Oncogene Proteins p21(ras)/blood

Key words

BRAF; Case report; Circulating tumor DNA; Colon cancer; Melanoma; Survivorship

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Neoplasms, Second Primary / Circulating Tumor DNA / Melanoma Limits: Aged / Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google